I have just come across this absolute gem. I don't normally get this excited, but must share it with others. Cobra is the name, listed on Aim and a market cap of 30 million. Just been awarded a US patent for a system that allows people to take previously injected drugs in tablet form. Already profitable was floated off from MLB last year (and given their fundraising today they may regret ever letting this one go).
Collins Stewart are predicting 1.8 million this year and 3.1 million next year, though i can see those numbers being left behind. The company is both exciting and defensive because some of the products that can be taken are against cancer, anthrax and other potentially fatal diseases. (Hoping of course there will never be another terrorist outrage but even then this stock would be one to have onside.) Turnover has doubled in the last twelve months and the potential really is amazing. Biotechs not usually my style but this one is already profitable and i just have to have some in my portfolio.

Perhaps Mr griffiths on UK-A hasn't heard of Cobra, otherwise why tip Proteome (Proteome: 6 million cash break even 2005 market cap 228 million) instead of Cobra (profitable now, doubled turnover, new patent, 7 million cash, market cap 28 million, same sector).
Crikey Andrew, sure proteome is a fine stock. But i know which I prefer. Gimme Cobra anytime!!

Latest recommendation - last week Evolution Beeson Gregory Ltd 02/03/2004 ADD

Anybody inerested in this stock? any views on current price looks cheap!

Hawick said "I have just come across this absolute gem. I don't normally get this excited"

It was about 150p when you posted hawick, are you excited at the now 30p offer?

TIA.

I told people elsewhere to get out when things started going wrong and it fell to 120p. Admittedly I did not update that suggestion on here, which was remiss, but I did say sell, very clearly, elsewhere. Management let people down very badly.

Just goes to show its a personal thing with thirdeye why else post on this thread, if I or Hawick were to expose the many and I mean many share tips that have gone belly up that Thirdeye as recommended we would have an awfull long list.

I say stop this silly childlike behaviour thirdeye, you are spoling this board.

GF don't worry about it, Third Eye only tends to tell people when to buy. When it comes to advising on his sales he is less diligent it seems. Have you sold Spectrum yet which you advised people to buy on here at 25p (now c13p), or are you still holding, Third Eye?

No blatent lies please hawick. Spectrum was advised to buy @ 12.5p when I bought, & that was another site (Unqouted) nothing to do with Cobra whatsover.

Shouldn't we be talking about cobra on this thread instead of diverting attention?

Gents,

As before, stick to the share and not fellow posters.

Ian

10 Dec'03 - 23:26 - 117 of 194
Well here's another for you Spectrum on Ofex a great recovery stock. Currently circa 20p....well worth checking out

Just for the record Ian, Third Eye said the above to money am readers. Not 25p, (though he must have thought it worth it to advise people to look at 20p, knowing its spread probably at least 21p to buy) but most certainly a lot further from 12.5p. now 13.75p. I note he has finally been banned from unquoted.

Ian I sent you a p-m a couple of weeks ago btw.

Now happy to return thread to Cobra, and accept i should have advised people to sell here when I clearly said sell elsewhere at 120p; (which is what i did).

Harwick,

I will be monitoring this thread from now on.

Ian

What has Spectrum got to do with this thread?

Worth looking at, doesn't say Buy, iyt says Worth looking at.

I bought at 12.5p & a search on Unquoted will verify this.


In fact I rarely say buy anbout any stock, although I have about Britannia up 355% & did about Sion up 300% in the bear market.

Hopefully this thread will now return to Cobra rather than Third Eye?

- this thread is COBRA - Hawick CBF was one you were excited about in Jan04 about 1.20 I think - now some bad news has been received, what is your take and DID you invest in Jan? -

Hangon you clearly have not read the whole thread. I was keen at 140p and said sell at 120p. Britannic have reduced their holding to just under a million. if they want shot of the rest that will continue to create overhang even at this level. Not time to look again and management needs to be shaken up meantime. Profit warning said break even then a loss of 1.8 million got announced.........

A bit of advice hawick, if you want to defend yourself that you said sell, any chance you could actually post it on MoneyAM rather than investors guess to which bulletin board you might have posted it on?









(Same for your rec on Cobra under Scotland on Aimquoted would be useful too btw)

ADMINISTRATORS you said you were watching this thread well surely the last post by thirdeye goes over the top and is not about the company but is a persional attack, just how long is it going to go before you give him his 3rd warning and deprive him of his posting rights?????????????????????????.

cheers GF.

Maybe you should both stop attacking each other? It's getting a little tedious here.

All,

I have watched this dispute across several threads for the past few weeks, and have had cause to comment on a number of occassions, as several posters have over stepped the mark. This has been the case for all involved on both sides of the discussion.

I am issuing a final warning for all those who have been involved - If I have cause to intervene with regard to any poster again, I will remove their access to these boards for a period of 24 hours. If I then have cause to warn that person any further I will remove their access from this part of the website completely.

I hope that I have made myself clear, and I hope that you all have a good day.

Regards

Ian Taylor
Customer Support Manager
MoneyAM

Leaving all other things aside this is a Bio-tech that is producing product in several areas. I think it was a part of ML Labs and some have suggested they should not have sold this business. The reduction in shareholding by Britannic is hardly a source of panic, having increased their holding some months ago to 6%+ their new holding is only just under 5% hardly likely to create an overhang or did the MM's panic?
Today, a Director bought 20,000 shares - OK not really newsworthy amount but it shows something. Hardly panic selling and I note the price is up 5%.
I class this small Bio along with Protherics (ie actually selling their stuff) - the fall-back in [CBF] US operation is unfortunate and has prompted this crisis IMHO - but many companies have dissapointments. I just don't think the Market read the earlier RNS since there is nothing "new" - that's my take.
I have bought at 29p so with spread I still not in profit, but hey it's only the first day.
I didn't understand "why" you thought it was a sell, was it the "warning" that alarmed you? The share-price had increased quite a bit, so maybe it was a tad overvalued. Now, though the NAV is 54p and the cash per share is above the Market price; can this be so bad right now?
I think it's been oversold but there is still a risk some other news is yet to be flushed out. However with such a fall it looks safe to me - I hope so.

You're right I read only the first page of comments - from Jan04 so this seemed reasonable to me.

Thank you for such an intelligent and cogent reply hangon, would someone else.......

I thought it a sell at 120p after the warning, which talked of break even. And then the loss came in at 1.8 million which did nothing for my confidence! Institutions are awfully slow to forgive and I feel management have let down investors badly. Trust is a key factor in share price performance and right now Cobra (rather like Raft) faces a big uphill struggle to win that back. Talk of sorting things out seems vague and that worries me from this managment! It'll be ok in 2005 all seems as i say vague.

All that said; you are spot on. A Director has bought. The nav is over 50p including a healthy cash position (but they cannot afford to continue burning it like they have done). And most likelable are some of the patents especially the syringe free ones.

There is hope therefore, and hence my interest (not financial) continues at these levels, but i would not buy back until i see some real evidence through at least one, preferably two, of the following: newsflow, numbers or management changes, of a turnaround.